• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    AdvanSix Announces Fourth Quarter and Full Year 2025 Financial Results

    2/20/26 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials
    Get the next $ASIX alert in real time by email

    4Q25 Sales of $360 million, up 9% versus prior year

    4Q25 Earnings Per Share of ($0.10); Adjusted Earnings Per Share of $0.03

    4Q25 Cash Flow from Operations of $64 million

    2025 planned plant turnarounds completed successfully at lower end of range

    Driving improved cash flow in 2026 through fixed cost savings, turnaround scope, risk-based prioritization of capital expenditures, and tax benefits

    AdvanSix (NYSE:ASIX), an integrated chemistry company serving diverse end markets, today announced its financial results for the fourth quarter and full year ending December 31, 2025. Overall, the Company had a strong finish to the year with its focus on optimizing operational and commercial performance to successfully navigate dynamic industry conditions.

    Full Year 2025 Summary

    Summary full year 2025 financial results for the Company are included below:

    ($ in Thousands, Except Earnings Per Share)

    FY 2025

     

    FY 2024

    Sales

    $1,522,233

     

    $1,517,557

    Net Income

    49,286

     

    44,149

    Diluted Earnings Per Share

    1.80

     

    1.62

    Adjusted Diluted Earnings Per Share (1)

    2.28

     

    1.96

    Adjusted EBITDA (1)

    156,798

     

    142,116

    Adjusted EBITDA Margin % (1)

    10.3%

     

    9.4%

    Cash Flow from Operations

    122,863

     

    135,413

    Capital Expenditures

    116,445

     

    133,722

    Free Cash Flow (1)(2)

    6,418

     

    1,691

    (1) See "Non-GAAP Measures" included in this press release for non-GAAP reconciliations

    (2) Net cash provided by operating activities less capital expenditures

    Sales by product line and approximate percentage of total sales are included below:

    ($ in Thousands)

    FY 2025

     

    FY 2024 (1)

     

    Sales

     

    % of Total

     

    Sales

     

    % of Total

    Nylon

    $

    309,678

     

    20%

     

    $

    348,501

     

    23%

    Caprolactam

     

    271,370

     

    18%

     

     

    276,303

     

    18%

    Plant Nutrients

     

    563,688

     

    37%

     

     

    458,152

     

    30%

    Chemical Intermediates

     

    377,497

     

    25%

     

     

    434,601

     

    29%

    Total

    $

    1,522,233

     

    100%

     

    $

    1,517,557

     

    100%

    (1) In 2024, the Company transferred certain products between its Chemical Intermediates product line and its Plant Nutrients product line to align more closely with its current sales structure. Historical information has been reclassified to reflect these changes for all periods presented in the Consolidated Financial Statements. Total revenue amounts were not impacted for either period.

    "The AdvanSix team executed well to close out 2025. We delivered full year Adjusted EBITDA of $157 million and generated positive free cash flow in a year characterized by continued cyclical trough market conditions for Nylon Solutions, robust Plant Nutrients supply and demand fundamentals amid a higher raw material input cost environment, and mixed Chemical Intermediates industry conditions with lower net pricing as anticipated," said Erin Kane, president and CEO of AdvanSix. "We generated these results while successfully executing our planned plant turnarounds, delivering record annual production across both of our key ammonia and sulfuric acid unit operations, funding key growth and enterprise initiatives including our SUSTAIN program, claiming additional 45Q carbon capture tax credits, receiving final settlement proceeds related to the 2019 PES supplier shutdown claim, preserving our competitive dividend and maintaining conservative debt leverage levels."

    Fourth Quarter 2025 Summary

    Summary fourth quarter 2025 financial results for the Company are included below:

    ($ in Thousands, Except Earnings Per Share)

    4Q 2025

     

    4Q 2024

    Sales

    $359,947

     

    $329,063

    Net Income (loss)

    (2,791)

     

    352

    Diluted Earnings Per Share

    (0.10)

     

    0.01

    Adjusted Diluted Earnings Per Share (1)

    0.03

     

    0.09

    Adjusted EBITDA (1)

    24,763

     

    10,219

    Adjusted EBITDA Margin % (1)

    6.9%

     

    3.1%

    Cash Flow from Operations

    63,722

     

    64,165

    Capital Expenditures

    27,596

     

    34,349

    Free Cash Flow (1)(2)

    36,126

     

    29,816

    (1) See "Non-GAAP Measures" included in this press release for non-GAAP reconciliations

    (2) Net cash provided by operating activities less capital expenditures

    Sales of $360 million in the quarter increased approximately 9% versus the prior year. Sales volume increased approximately 11% primarily driven by the prior year impact of the 4Q24 extended planned turnaround. Market-based pricing was favorable by approximately 2% driven by continued strength in Plant Nutrients, reflecting favorable North American ammonium sulfate supply and demand conditions, partially offset by lower acetone prices as anticipated. Raw material pass-through pricing was down approximately 4% following a net cost decrease in benzene and propylene (inputs to cumene which is a key feedstock to our products).

    Sales by product line and approximate percentage of total sales are included below:

    ($ in Thousands)

    4Q 2025

     

    4Q 2024 (1)

     

    Sales

     

    % of Total

     

    Sales

     

    % of Total

    Nylon

    $

    62,778

     

    17%

     

    $

    67,172

     

    21%

    Caprolactam

     

    64,377

     

    18%

     

     

    57,216

     

    17%

    Plant Nutrients

     

    139,991

     

    39%

     

     

    102,566

     

    31%

    Chemical Intermediates

     

    92,801

     

    26%

     

     

    102,109

     

    31%

    Total

    $

    359,947

     

    100%

     

    $

    329,063

     

    100%

    (1) In 2024, the Company transferred certain products between its Chemical Intermediates product line and its Plant Nutrients product line to align more closely with its current sales structure. Historical information has been reclassified to reflect these changes for all periods presented in the Consolidated Financial Statements. Total revenue amounts were not impacted for either period.

    Adjusted EBITDA of $24.8 million in the quarter increased $14.5 million versus the prior year primarily driven by the favorable year-over-year volume and cost impact of plant turnarounds, partially offset by a decline in Chemical Intermediates pricing, net of raw material costs.

    Adjusted earnings per share of $0.03 decreased $0.06 versus the prior year driven primarily by the factors discussed above, which were more than offset by the $9.7 million in 45Q carbon capture tax credits claimed in the fourth quarter of 2024.

    Cash flow from operations of $63.7 million in the quarter decreased $0.4 million versus the prior year primarily due to lower ammonium sulfate pre-buy cash advances partially offset by other changes in working capital. Capital expenditures of $27.6 million in the quarter decreased $6.8 million versus the prior year.

    Outlook

    • Anticipate continued strength in Plant Nutrients supply and demand fundamentals amid meaningfully higher sulfur input costs
    • Acetone spread over propylene costs expected to hold near cycle averages; Anti-dumping duties into U.S. renewed for another five years
    • Navigating an extended trough in the nylon cycle - focused on controllable levers to optimize performance
    • Expect Capital Expenditures of $75 to $95 million in 2026 versus approximately $116 million in 2025, reflecting a risk-based prioritization of base investments and enterprise programs with continued progression of growth programs including SUSTAIN
    • Expect pre-tax income impact of plant turnarounds to be $20 to $25 million in 2026 versus approximately $25 million in 2025
    • Expect cash flow benefit in 2026 and beyond from 45Q carbon capture tax credits and 100% bonus depreciation

    "The end market environment entering 2026 remains mixed overall. We've seen continued strength in Plant Nutrients and acetone margins remain near cycle averages, while nylon has plateaued in its trough. Conversely, there have been several recent industry announcements pointing to capacity rationalization and lower operating rates, which we believe should lead to more favorable supply and demand conditions over time. We remain highly focused on delivering on controllable levers including continued optimization of production output and sales volume mix while driving productivity to support through-cycle profitability. We have embarked on a multi-year non-manpower fixed cost savings program targeting approximately $30 million of annual savings. In addition, we now anticipate capital expenditures to be in the range of $75 to $95 million in 2026 driven by a risk-based prioritization of our capital investments and keen focus on cash flow generation and conversion. Our strategic initiatives, unique combination of assets and business model are core to our durable competitive advantage and long-term positioning," concluded Kane.

    Dividend

    The Company's Board of Directors declared a quarterly cash dividend of $0.16 per share on the Company's common stock. The dividend is payable on March 23, 2026 to stockholders of record as of the close of business on March 9, 2026.

    Conference Call Information

    AdvanSix will discuss its results during its investor conference call today starting at 9:30 a.m. ET. To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start, and tell the operator that you are dialing in for AdvanSix's fourth quarter 2025 earnings call. The live webcast of the investor call as well as related presentation materials can be accessed at http://investors.advansix.com. Investors can hear a replay of the conference call from 12 noon ET on February 20 until 12 noon ET on February 27 by dialing (855) 669-9658 (domestic) or (412) 317-0088 (international). The access code is 2514016.

    About AdvanSix

    AdvanSix is an integrated chemistry company that produces essential materials for our customers across diverse end markets. Our value chain of our five U.S.-based manufacturing facilities plays a critical role in global supply chains and enables us to innovate and deliver essential products for our customers across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, electronics and other end markets. Guided by our core values of Safety, Integrity, Accountability and Respect, AdvanSix strives to deliver best-in-class customer experiences and differentiated products in the industries of nylon solutions, plant nutrients, and chemical intermediates. More information on AdvanSix can be found at http://www.advansix.com.

    Forward Looking Statements

    This release contains certain statements that may be deemed "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, that address activities, events or developments that our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements may be identified by words such as "expect," "anticipate," "estimate," "outlook," "project," "strategy," "intend," "plan," "target," "goal," "may," "will," "should" and "believe" and other variations or similar terminology and expressions. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties and other factors, many of which are beyond our control and difficult to predict, which may cause the actual results or performance of the Company to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: general economic and financial conditions in the U.S. and globally; the potential effects of inflationary pressures, tariffs or the imposition of new tariffs, trade wars, barriers or restrictions, or threats of such actions, changes in interest rates, labor market shortages and supply chain issues; instability or volatility in financial markets or other unfavorable economic or business conditions caused by geopolitical concerns, including as a result of new or proposed legislation or regulatory, trade or other policies in or impacting the U.S., the conflict between Russia and Ukraine, the conflicts in Israel, Gaza and Iran, and related uncertainty in the surrounding region, and the possible expansion of such conflicts; the effect of any of the foregoing on our customers' demand for our products and our suppliers' ability to manufacture and deliver our raw materials, including implications of reduced refinery utilization in the U.S.; our ability to sell and provide our goods and services; the ability of our customers to pay for our products; any closures of our and our customers' offices and facilities; risks associated with increased phishing, compromised business emails and other cybersecurity attacks, data privacy incidents and disruptions to our technology infrastructure; risks associated with potential use of artificial intelligence in our operations or those of third party service providers; risks associated with operating with a reduced workforce; risks associated with our indebtedness including compliance with financial and restrictive covenants, and our ability to access capital on reasonable terms, at a reasonable cost, or at all, due to economic conditions or otherwise; the impact of scheduled turnarounds and significant unplanned downtime and interruptions of production or logistics operations as a result of mechanical issues or other unanticipated events such as fires, severe weather conditions, natural disasters, pandemics, geopolitical conflicts and related events; price fluctuations, cost increases and supply of raw materials; our operations and growth projects requiring substantial capital; growth rates and cyclicality of the industries we serve including global changes in supply and demand; failure to develop and commercialize new products or technologies; loss of significant customer relationships; adverse trade and tax policies; extensive environmental, health and safety laws that apply to our operations; hazards associated with chemical manufacturing, storage and transportation; litigation associated with chemical manufacturing and our business operations generally; inability to acquire and integrate businesses, assets, products or technologies; protection of our intellectual property and proprietary information; prolonged work stoppages as a result of labor difficulties or otherwise; failure to maintain effective internal controls; our ability to declare and pay quarterly cash dividends and the amounts and timing of any future dividends; our ability to repurchase our common stock and the amount and timing of any future repurchases; disruptions in supply chain, transportation and logistics; potential for uncertainty regarding qualification for tax treatment of our spin-off; fluctuations in our stock price; and changes in laws or regulations applicable to our business. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ materially from those contemplated by such forward-looking statements as a result of a number of risks, uncertainties and other factors including those noted above and those identified in our filings with the Securities and Exchange Commission (SEC), including the risk factors in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2024, as updated in subsequent reports filed with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. We do not undertake to update or revise any of our forward-looking statements.

    Non-GAAP Financial Measures

    This press release includes certain non-GAAP financial measures intended to supplement, not to act as substitutes for, comparable GAAP measures. Reconciliations of non-GAAP financial measures to GAAP financial measures are provided in this press release. Investors are urged to consider carefully the comparable GAAP measures and the reconciliations to those measures provided. Non-GAAP measures in this press release may be calculated in a way that is not comparable to similarly-titled measures reported by other companies.

    AdvanSix Inc.

    Consolidated Balance Sheets

    (Unaudited)

    (Dollars in thousands, except share and per share amounts)

     

     

    December 31, 2025

     

    December 31, 2024

    ASSETS

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    19,766

     

     

    $

    19,564

     

    Accounts and other receivables – net

     

    154,102

     

     

     

    145,673

     

    Inventories – net

     

    236,495

     

     

     

    212,386

     

    Taxes receivable

     

    21,605

     

     

     

    503

     

    Other current assets

     

    8,639

     

     

     

    8,990

     

    Total current assets

     

    440,607

     

     

     

    387,116

     

    Property, plant and equipment – net

     

    963,718

     

     

     

    917,858

     

    Operating lease right-of-use assets

     

    164,494

     

     

     

    153,438

     

    Goodwill

     

    56,192

     

     

     

    56,192

     

    Intangible assets

     

    40,095

     

     

     

    43,144

     

    Other assets

     

    41,042

     

     

     

    37,172

     

    Total assets

    $

    1,706,148

     

     

    $

    1,594,920

     

     

     

     

     

    LIABILITIES

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

    $

    284,016

     

     

    $

    228,761

     

    Accrued liabilities

     

    45,945

     

     

     

    47,264

     

    Income taxes payable

     

    1,100

     

     

     

    1,047

     

    Operating lease liabilities – short-term

     

    44,354

     

     

     

    42,493

     

    Deferred income and customer advances

     

    14,536

     

     

     

    37,538

     

    Total current liabilities

     

    389,951

     

     

     

    357,103

     

    Deferred income taxes

     

    154,061

     

     

     

    145,299

     

    Operating lease liabilities – long-term

     

    121,201

     

     

     

    111,400

     

    Line of credit – long-term

     

    215,000

     

     

     

    195,000

     

    Other liabilities

     

    10,719

     

     

     

    11,468

     

    Total liabilities

     

    890,932

     

     

     

    820,270

     

     

     

     

     

    STOCKHOLDERS' EQUITY

     

     

     

    Common stock, par value $0.01; 200,000,000 shares authorized; 33,177,824 shares issued and 26,864,035 outstanding at December 31, 2025; 32,989,165 shares issued and 26,737,036 outstanding at December 31, 2024

     

    332

     

     

     

    330

     

    Preferred stock, par value $0.01; 50,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2025 and December 31, 2024

     

    —

     

     

     

    —

     

    Treasury stock at par (6,313,789 shares at December 31, 2025; 6,252,129 shares at December 31, 2024)

     

    (63

    )

     

     

    (63

    )

    Additional paid-in capital

     

    142,932

     

     

     

    136,872

     

    Retained earnings

     

    663,019

     

     

     

    631,541

     

    Accumulated other comprehensive income

     

    8,996

     

     

     

    5,970

     

    Total stockholders' equity

     

    815,216

     

     

     

    774,650

     

    Total liabilities and stockholders' equity

    $

    1,706,148

     

     

    $

    1,594,920

     

    AdvanSix Inc.

    Consolidated Statements of Operations

    (Unaudited)

    (Dollars in thousands, except share and per share amounts)

     

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

    Sales

    $

    359,947

     

     

    $

    329,063

     

     

    $

    1,522,233

     

     

    $

    1,517,557

     

     

     

     

     

     

     

     

    Costs, expenses and other:

     

     

     

     

     

     

     

    Cost of goods sold

     

    332,576

     

     

     

    317,762

     

     

     

    1,357,293

     

     

     

    1,364,621

    Selling, general and administrative expenses

     

    28,499

     

     

     

    21,734

     

     

     

    104,750

     

     

     

    94,023

    Interest expense, net

     

    2,363

     

     

     

    2,174

     

     

     

    8,481

     

     

     

    11,311

    Other non-operating (income) expense, net

     

    (890

    )

     

     

    218

     

     

     

    (2,722

    )

     

     

    2,027

    Total costs, expenses and other

     

    362,548

     

     

     

    341,888

     

     

     

    1,467,802

     

     

     

    1,471,982

     

     

     

     

     

     

     

     

    Income (loss) before taxes

     

    (2,601

    )

     

     

    (12,825

    )

     

     

    54,431

     

     

     

    45,575

    Income tax expense (benefit)

     

    190

     

     

     

    (13,177

    )

     

     

    5,145

     

     

     

    1,426

    Net income (loss)

    $

    (2,791

    )

     

    $

    352

     

     

    $

    49,286

     

     

    $

    44,149

     

     

     

     

     

     

     

     

    Earnings per common share

     

     

     

     

     

     

     

    Basic

    $

    (0.10

    )

     

    $

    0.01

     

     

    $

    1.83

     

     

    $

    1.65

    Diluted

    $

    (0.10

    )

     

    $

    0.01

     

     

    $

    1.80

     

     

    $

    1.62

     

     

     

     

     

     

     

     

    Weighted average common shares outstanding

     

     

     

     

     

     

     

    Basic

     

    26,941,274

     

     

     

    26,805,182

     

     

     

    26,901,046

     

     

     

    26,828,338

    Diluted

     

    26,941,274

     

     

     

    27,234,784

     

     

     

    27,327,449

     

     

     

    27,255,213

    AdvanSix Inc.

    Consolidated Statements of Cash Flows

    (Unaudited)

    (Dollars in thousands)

     

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Cash flows from operating activities:

     

     

     

     

     

     

     

    Net income (loss)

    $

    (2,791

    )

     

    $

    352

     

     

    $

    49,286

     

     

    $

    44,149

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

     

     

     

     

    Depreciation and amortization

     

    20,774

     

     

     

    18,979

     

     

     

    79,740

     

     

     

    76,176

     

    (Gain) loss on disposal of assets

     

    96

     

     

     

    358

     

     

     

    (81

    )

     

     

    773

     

    Deferred income taxes

     

    (6,645

    )

     

     

    (12,629

    )

     

     

    7,821

     

     

     

    (8,991

    )

    Stock-based compensation

     

    902

     

     

     

    1,891

     

     

     

    6,821

     

     

     

    7,854

     

    Amortization of deferred financing fees

     

    133

     

     

     

    154

     

     

     

    597

     

     

     

    618

     

    Operational asset adjustments

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    1,200

     

    Changes in assets and liabilities, net of business acquisitions:

     

     

     

     

     

     

     

    Accounts and other receivables

     

    30,576

     

     

     

    3,342

     

     

     

    (8,395

    )

     

     

    18,411

     

    Inventories

     

    (27,375

    )

     

     

    1,048

     

     

     

    (24,109

    )

     

     

    (555

    )

    Taxes receivable

     

    2,153

     

     

     

    (128

    )

     

     

    (21,102

    )

     

     

    931

     

    Accounts payable

     

    36,320

     

     

     

    13,077

     

     

     

    52,866

     

     

     

    (30,610

    )

    Income taxes payable

     

    1,051

     

     

     

    612

     

     

     

    53

     

     

     

    (6,986

    )

    Accrued liabilities

     

    (9,721

    )

     

     

    (8,562

    )

     

     

    (808

    )

     

     

    2,426

     

    Deferred income and customer advances

     

    13,855

     

     

     

    36,021

     

     

     

    (23,002

    )

     

     

    21,860

     

    Other assets and liabilities

     

    4,394

     

     

     

    9,650

     

     

     

    3,176

     

     

     

    8,157

     

    Net cash provided by operating activities

     

    63,722

     

     

     

    64,165

     

     

     

    122,863

     

     

     

    135,413

     

     

     

     

     

     

     

     

     

    Cash flows from investing activities:

     

     

     

     

     

     

     

    Expenditures for property, plant and equipment

     

    (27,596

    )

     

     

    (34,349

    )

     

     

    (116,445

    )

     

     

    (133,722

    )

    Other investing activities

     

    (16

    )

     

     

    (3,127

    )

     

     

    (6,169

    )

     

     

    (9,180

    )

    Net cash used for investing activities

     

    (27,612

    )

     

     

    (37,476

    )

     

     

    (122,614

    )

     

     

    (142,902

    )

     

     

     

     

     

     

     

     

    Cash flows from financing activities:

     

     

     

     

     

     

     

    Borrowings from line of credit

     

    54,000

     

     

     

    94,500

     

     

     

    370,500

     

     

     

    406,000

     

    Repayments of line of credit

     

    (89,000

    )

     

     

    (114,500

    )

     

     

    (350,500

    )

     

     

    (381,000

    )

    Payment of line of credit facility fees

     

    (478

    )

     

     

    —

     

     

     

    (478

    )

     

     

    —

     

    Principal payments of finance leases

     

    (262

    )

     

     

    (249

    )

     

     

    (1,002

    )

     

     

    (1,011

    )

    Dividend payments

     

    (4,300

    )

     

     

    (4,277

    )

     

     

    (17,176

    )

     

     

    (17,135

    )

    Purchase of treasury stock

     

    —

     

     

     

    (1

    )

     

     

    (1,658

    )

     

     

    (10,428

    )

    Issuance of common stock

     

    —

     

     

     

    104

     

     

     

    267

     

     

     

    859

     

    Net cash used for financing activities

     

    (40,040

    )

     

     

    (24,423

    )

     

     

    (47

    )

     

     

    (2,715

    )

     

     

     

     

     

     

     

     

    Net change in cash and cash equivalents

     

    (3,930

    )

     

     

    2,266

     

     

     

    202

     

     

     

    (10,204

    )

    Cash and cash equivalents at beginning of period

     

    23,696

     

     

     

    17,298

     

     

     

    19,564

     

     

     

    29,768

     

    Cash and cash equivalents at the end of period

    $

    19,766

     

     

    $

    19,564

     

     

    $

    19,766

     

     

    $

    19,564

     

     

     

     

     

     

     

     

     

    Supplemental non-cash investing activities:

     

     

     

     

     

     

     

    Capital expenditures included in accounts payable

     

     

     

     

    $

    26,670

     

     

    $

    23,645

     

    AdvanSix Inc.

    Non-GAAP Measures

    (Dollars in thousands, except share and per share amounts)

     

    Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow

     

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Net cash provided by operating activities

    $

    63,722

     

     

    $

    64,165

     

     

    $

    122,863

     

     

    $

    135,413

     

    Expenditures for property, plant and equipment

     

    (27,596

    )

     

     

    (34,349

    )

     

     

    (116,445

    )

     

     

    (133,722

    )

    Free cash flow (1)

    $

    36,126

     

     

    $

    29,816

     

     

    $

    6,418

     

     

    $

    1,691

     

     

     

     

     

     

     

     

     

    (1) Free cash flow is a non-GAAP measure defined as Net cash provided by operating activities less Expenditures for property, plant and equipment.

    The Company believes that this metric is useful to investors and management as a measure to evaluate our ability to generate cash flow from business operations and the impact that this cash flow has on our liquidity.

    Reconciliation of Net Income to Adjusted EBITDA and Earnings Per Share to Adjusted Earnings Per Share
     

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Net income (loss)

    $

    (2,791

    )

     

    $

    352

     

     

    $

    49,286

     

     

    $

    44,149

     

    Non-cash stock-based compensation

     

    902

     

     

     

    1,891

     

     

     

    6,821

     

     

     

    7,854

     

    Non-recurring, unusual or extraordinary expense (2)

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    1,200

     

    Non-cash amortization from acquisitions

     

    532

     

     

     

    531

     

     

     

    2,127

     

     

     

    2,126

     

    Strategic advisory and professional fees (3)

     

    3,325

     

     

     

    —

     

     

     

    7,325

     

     

     

    —

     

    Income tax benefit relating to reconciling items

     

    (1,099

    )

     

     

    (417

    )

     

     

    (3,386

    )

     

     

    (2,011

    )

    Adjusted Net income (non-GAAP)

     

    869

     

     

     

    2,357

     

     

     

    62,173

     

     

     

    53,318

     

    Interest expense, net

     

    2,363

     

     

     

    2,174

     

     

     

    8,481

     

     

     

    11,311

     

    Income tax expense (benefit) - Adjusted

     

    1,289

     

     

     

    (12,760

    )

     

     

    8,531

     

     

     

    3,437

     

    Depreciation and amortization - Adjusted

     

    20,242

     

     

     

    18,448

     

     

     

    77,613

     

     

     

    74,050

     

    Adjusted EBITDA (non-GAAP)

    $

    24,763

     

     

    $

    10,219

     

     

    $

    156,798

     

     

    $

    142,116

     

     

     

     

     

     

     

     

     

    Sales

    $

    359,947

     

     

    $

    329,063

     

     

    $

    1,522,233

     

     

    $

    1,517,557

     

     

     

     

     

     

     

     

     

    Adjusted EBITDA Margin (non-GAAP) (4)

     

    6.9

    %

     

     

    3.1

    %

     

     

    10.3

    %

     

     

    9.4

    %

     

     

     

     

     

     

     

     

    (2) 2024 includes a pre-tax loss of approximately $1.2 million from the reduction of the Company's anticipated receivable related to the gain on the termination fee recorded upon the exit from the Oben Holding Group S.A. alliance during the third quarter of 2023

    (3) Legal and professional fees associated with strategic regulatory matters and potential inorganic growth options, including costs associated with a transaction the Company is no longer pursuing

    (4) Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by Sales

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

     

    2025

     

     

     

    2024

     

     

    2025

     

     

    2024

    Net income (loss)

    $

    (2,791

    )

     

    $

    352

     

    $

    49,286

     

    $

    44,149

    Adjusted Net income (non-GAAP)

     

    869

     

     

     

    2,357

     

     

    62,173

     

     

    53,318

     

     

     

     

     

     

     

     

    Weighted-average number of common shares outstanding - basic

     

    26,941,274

     

     

     

    26,805,182

     

     

    26,901,046

     

     

    26,828,338

    Dilutive effect of equity awards and other stock-based holdings

     

    —

     

     

     

    429,602

     

     

    426,403

     

     

    426,875

    Weighted-average number of common shares outstanding - diluted

     

    26,941,274

     

     

     

    27,234,784

     

     

    27,327,449

     

     

    27,255,213

     

     

     

     

     

     

     

     

    EPS - Basic

    $

    (0.10

    )

     

    $

    0.01

     

    $

    1.83

     

    $

    1.65

    EPS - Diluted

    $

    (0.10

    )

     

    $

    0.01

     

    $

    1.80

     

    $

    1.62

    Adjusted EPS - Basic (non-GAAP)

    $

    0.03

     

     

    $

    0.09

     

    $

    2.31

     

    $

    1.99

    Adjusted EPS - Diluted (non-GAAP)

    $

    0.03

     

     

    $

    0.09

     

    $

    2.28

     

    $

    1.96

    The Company believes the non-GAAP financial measures presented in this release provide meaningful supplemental information as they are used by the Company's management to evaluate the Company's operating performance, enhance a reader's understanding of the financial performance of the Company, and facilitate a better comparison among fiscal periods and performance relative to its competitors, as these non-GAAP measures exclude items that are not considered core to the Company's operations.

    AdvanSix Inc.

    Appendix

    (Pre-tax income impact, Dollars in millions)

     

    Planned Plant Turnaround Schedule (4)

     

     

    1Q

     

    2Q

     

    3Q

     

    4Q

     

    FY

     

    Primary Unit Operation

    2017

    —

     

    ~$10

     

    ~$4

     

    ~$20

     

    ~$34

     

    Sulfuric Acid

    2018

    ~$2

     

    ~$10

     

    ~$30

     

    —

     

    ~$42

     

    Ammonia

    2019

    —

     

    ~$5

     

    ~$5

     

    ~$25

     

    ~$35

     

    Sulfuric Acid

    2020

    ~$2

     

    ~$7

     

    ~$20

     

    ~$2

     

    ~$31

     

    Ammonia

    2021

    ~$3

     

    ~$8

     

    —

     

    ~$18

     

    ~$29

     

    Sulfuric Acid

    2022

    ~$1

     

    ~$5

     

    ~$44(5)

     

    —

     

    ~$50

     

    Ammonia

    2023

    ~$2

     

    ~$1

     

    ~$27

     

    —

     

    ~$30

     

    Sulfuric Acid

    2024

    ~$5

     

    ~$3

     

    ~$3

     

    ~$47(6)

     

    ~$58

     

    Ammonia

    2025

    ~$5

     

    ~$6

     

    —

     

    ~$14

     

    ~$25

     

    Sulfuric Acid

    2026E

    ~$3

     

    $10-$15

     

    —

     

    ~$7

     

    $20-$25

     

    Ammonia

    (4) Primarily reflects the impact of fixed cost absorption, maintenance expense, and the purchase of feedstocks which are normally manufactured by the Company.

    (5) During the multi-site planned plant turnaround, additional required maintenance at our Frankford phenol plant contributed to reduced production across our integrated value chain and a delayed ramp to full operating rates at our Hopewell and Chesterfield sites, resulting in an incremental $15 million unfavorable impact to pre-tax income, which is reflected in this amount and is inclusive of fixed cost absorption, higher maintenance expense and lost sales.

    (6) During the multi-site planned plant turnaround, additional required maintenance at our Hopewell plant contributed to reduced production across our integrated value chain and a delayed ramp to full operating rates, resulting in an incremental approximately $17 million unfavorable impact to pre-tax income, which is reflected in this amount and is inclusive of fixed cost absorption, higher maintenance expense, and lost sales.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260219417617/en/

    Media

    Janeen Lawlor

    (973) 526-1615

    [email protected]

    Investors

    Adam Kressel

    (973) 526-1700

    [email protected]

    Get the next $ASIX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASIX

    DatePrice TargetRatingAnalyst
    1/15/2026$19.00Hold
    Truist
    5/19/2025$32.00Neutral → Overweight
    Piper Sandler
    4/7/2025$26.00Overweight → Neutral
    Piper Sandler
    11/12/2021$58.00Overweight
    Piper Sandler
    More analyst ratings

    $ASIX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Truist initiated coverage on AdvanSix with a new price target

    Truist initiated coverage of AdvanSix with a rating of Hold and set a new price target of $19.00

    1/15/26 8:33:55 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded AdvanSix from Neutral to Overweight and set a new price target of $32.00

    5/19/25 8:45:52 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded AdvanSix from Overweight to Neutral and set a new price target of $26.00

    4/7/25 8:48:39 AM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    SEC Filings

    View All

    SEC Form 10-K filed by AdvanSix Inc.

    10-K - AdvanSix Inc. (0001673985) (Filer)

    2/20/26 4:17:22 PM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - AdvanSix Inc. (0001673985) (Filer)

    2/20/26 6:30:17 AM ET
    $ASIX
    Major Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by AdvanSix Inc.

    SCHEDULE 13G/A - AdvanSix Inc. (0001673985) (Subject)

    2/11/26 1:44:06 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    VP and Interim CFO Gramm Christopher covered exercise/tax liability with 2,624 shares, decreasing direct ownership by 3% to 73,025 units (SEC Form 4)

    4 - AdvanSix Inc. (0001673985) (Issuer)

    3/3/26 4:58:06 PM ET
    $ASIX
    Major Chemicals
    Industrials

    SVP, General Counsel Kintiroglou Achilles B. covered exercise/tax liability with 8,008 shares, decreasing direct ownership by 14% to 50,363 units (SEC Form 4)

    4 - AdvanSix Inc. (0001673985) (Issuer)

    3/3/26 4:56:15 PM ET
    $ASIX
    Major Chemicals
    Industrials

    SVP, Chief HR Officer Slieter Kelly covered exercise/tax liability with 5,424 shares, decreasing direct ownership by 8% to 65,029 units (SEC Form 4)

    4 - AdvanSix Inc. (0001673985) (Issuer)

    3/3/26 4:54:21 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AdvanSix Announces Fourth Quarter and Full Year 2025 Financial Results

    4Q25 Sales of $360 million, up 9% versus prior year 4Q25 Earnings Per Share of ($0.10); Adjusted Earnings Per Share of $0.03 4Q25 Cash Flow from Operations of $64 million 2025 planned plant turnarounds completed successfully at lower end of range Driving improved cash flow in 2026 through fixed cost savings, turnaround scope, risk-based prioritization of capital expenditures, and tax benefits AdvanSix (NYSE:ASIX), an integrated chemistry company serving diverse end markets, today announced its financial results for the fourth quarter and full year ending December 31, 2025. Overall, the Company had a strong finish to the year with its focus on optimizing operational and commercial

    2/20/26 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix to Release Fourth Quarter Financial Results and Hold Investor Conference Call on February 20

    AdvanSix (NYSE:ASIX), an integrated chemistry company serving diverse end markets, will issue its fourth quarter and full year 2025 financial results before the opening of the New York Stock Exchange on Friday, February 20. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's fourth quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on February 20 until 12 noon ET on Febru

    1/20/26 6:50:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Appoints Jeffrey J. Bird to Board of Directors

    AdvanSix (NYSE:ASIX), an integrated chemistry company serving diverse end markets, announced today the appointment of Jeffrey J. Bird as a new independent member of its Board of Directors, effective January 1, 2026. Mr. Bird is currently Interim President and Chief Operating Officer of Envent Corporation, a private company that provides environmental and industrial solutions for the petrochemical industry that minimize environmental impact while maximizing operational efficiency, where he has also served as a member of the Board of Advisors since January 2025. He also serves as a director of Heath Consultants, a private company specializing in methane detection. With Mr. Bird's appointm

    12/22/25 4:15:00 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Newman Donald P bought $149,089 worth of shares (5,030 units at $29.64) (SEC Form 4)

    4 - AdvanSix Inc. (0001673985) (Issuer)

    11/19/24 4:20:20 PM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Financials

    Live finance-specific insights

    View All

    AdvanSix Announces Fourth Quarter and Full Year 2025 Financial Results

    4Q25 Sales of $360 million, up 9% versus prior year 4Q25 Earnings Per Share of ($0.10); Adjusted Earnings Per Share of $0.03 4Q25 Cash Flow from Operations of $64 million 2025 planned plant turnarounds completed successfully at lower end of range Driving improved cash flow in 2026 through fixed cost savings, turnaround scope, risk-based prioritization of capital expenditures, and tax benefits AdvanSix (NYSE:ASIX), an integrated chemistry company serving diverse end markets, today announced its financial results for the fourth quarter and full year ending December 31, 2025. Overall, the Company had a strong finish to the year with its focus on optimizing operational and commercial

    2/20/26 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix to Release Fourth Quarter Financial Results and Hold Investor Conference Call on February 20

    AdvanSix (NYSE:ASIX), an integrated chemistry company serving diverse end markets, will issue its fourth quarter and full year 2025 financial results before the opening of the New York Stock Exchange on Friday, February 20. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's fourth quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on February 20 until 12 noon ET on Febru

    1/20/26 6:50:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    AdvanSix Announces Third Quarter 2025 Financial Results

    3Q25 Sales of $374 million, down 6% versus prior year 3Q25 Earnings Per Share of ($0.10); Adjusted Earnings Per Share of $0.08 3Q25 Cash Flow from Operations of $27 million AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the third quarter ending September 30, 2025. Overall, the Company continued to navigate challenging industry dynamics with a focus on optimizing operational and commercial performance. Third Quarter 2025 Summary "In the third quarter, our team executed with agility and discipline as we seasonally entered a new fertilizer year in Plant Nutrients with a strong fall fill program, amid higher raw material input costs, while

    11/7/25 6:30:00 AM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

    SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

    2/13/24 4:55:58 PM ET
    $ASIX
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

    SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

    2/9/24 9:58:57 AM ET
    $ASIX
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by AdvanSix Inc.

    SC 13G - AdvanSix Inc. (0001673985) (Subject)

    2/7/24 8:39:58 AM ET
    $ASIX
    Major Chemicals
    Industrials

    $ASIX
    Leadership Updates

    Live Leadership Updates

    View All

    AdvanSix Appoints Jeffrey J. Bird to Board of Directors

    AdvanSix (NYSE:ASIX), an integrated chemistry company serving diverse end markets, announced today the appointment of Jeffrey J. Bird as a new independent member of its Board of Directors, effective January 1, 2026. Mr. Bird is currently Interim President and Chief Operating Officer of Envent Corporation, a private company that provides environmental and industrial solutions for the petrochemical industry that minimize environmental impact while maximizing operational efficiency, where he has also served as a member of the Board of Advisors since January 2025. He also serves as a director of Heath Consultants, a private company specializing in methane detection. With Mr. Bird's appointm

    12/22/25 4:15:00 PM ET
    $ASIX
    Major Chemicals
    Industrials

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    AdvanSix Appoints Dana O'Brien and Daryl Roberts to Board of Directors

    AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Dana O'Brien and Daryl Roberts as new independent members of its Board of Directors. Ms. O'Brien recently retired as Senior Vice President and Chief Legal Officer of Olin Corporation, a leading vertically integrated global manufacturer and distributor of chemical products. Ms. O'Brien will serve on the Nominating and Governance Committee and the Compensation and Leadership Development Committee of the Board. Mr. Roberts is currently Senior Vice President and Chief Operations and Engineering Officer of DuPont de Nemours Inc., a global innovation leader with technology-based materials and solutions t

    9/2/25 4:15:00 PM ET
    $ASIX
    Major Chemicals
    Industrials